BlackRock
DERM icon

BlackRock’s Journey Medical DERM Stock Holding History

BlackRock’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$715K Sell
100,981
-871,881
-90% -$4.98M ﹤0.01% 4468
2026
Q1 		$4.56M Buy
972,862
+253,078
+35% +$1.96M ﹤0.01% 3868
2025
Q4 		$5.55M Buy
719,784
+86,725
+14% +$680K ﹤0.01% 3793
2025
Q3 		$4.51M Buy
633,059
+88,717
+16% +$644K ﹤0.01% 3819
2025
Q2 		$3.91M Buy
544,342
+491,108
+923% +$3.39M ﹤0.01% 3865
2025
Q1 		$314K Buy
53,234
+492
+0.9% +$2.42K ﹤0.01% 4516
2024
Q4 		$206K Buy
52,742
+124
+0.2% +$678 ﹤0.01% 4616
2024
Q3 		$297K Buy
52,618
+754
+1% +$3.88K ﹤0.01% 4443
2024
Q2 		$293K Buy
51,864
+2,455
+5% +$10.1K ﹤0.01% 4469
2024
Q1 		$182K Buy
49,409
+5,517
+13% +$24K ﹤0.01% 4608
2023
Q4 		$253K Buy
43,892
+29,500
+205% +$131K ﹤0.01% 4580
2023
Q3 		$39.4K Sell
14,392
-609
-4% -$1.36K ﹤0.01% 5042
2023
Q2 		$23.9K Buy
15,001
+6,273
+72% +$10.1K ﹤0.01% 5185
2023
Q1 		$13.7K Buy
8,728
+282
+3% +$526 ﹤0.01% 5296
2022
Q4 		$16.2K Buy
8,446
+188
+2% +$372 ﹤0.01% 5398
2022
Q3 		$21K Sell
8,258
-235
-3% -$801 ﹤0.01% 5499
2022
Q2 		$32K Sell
8,493
-141
-2% -$558 ﹤0.01% 5489
2022
Q1 		$41K Sell
8,634
-694
-7% -$3.46K ﹤0.01% 5451
2021
Q4 		$50K Buy
+9,328
New +$67.6K ﹤0.01% 5401

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock's DERM Position: Q2 2026 in Review

BlackRock reduced its Journey Medical (DERM) stake by 90% in Q2 2026, selling an estimated $4.98M and leaving 100,981 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #4468.

BlackRock first reported a position in DERM in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.55M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • BlackRock held 100,981 shares of Journey Medical worth $715K as of Q2 2026.
  • BlackRock sold 871,881 Journey Medical shares in Q2 2026, an estimated $4.98M.
  • Journey Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4468 holding.
  • BlackRock first reported a position in Journey Medical in Q4 2021 and has held it in 19 quarters since.
  • BlackRock's Journey Medical position peaked at $5.55M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.